Clinton Group Inc. purchased a new stake in Cardiovascular Systems, Inc. (NASDAQ:CSII) during the first quarter, Holdings Channel reports. The institutional investor purchased 7,486 shares of the medical device company’s stock, valued at approximately $212,000.

Several other large investors have also modified their holdings of the company. Quantbot Technologies LP increased its stake in shares of Cardiovascular Systems by 142.3% in the first quarter. Quantbot Technologies LP now owns 5,323 shares of the medical device company’s stock valued at $150,000 after buying an additional 3,126 shares during the last quarter. Winslow Evans & Crocker Inc. acquired a new stake in shares of Cardiovascular Systems during the first quarter valued at $153,000. Old Mutual Global Investors UK Ltd. acquired a new stake in shares of Cardiovascular Systems during the first quarter valued at $163,000. UBS Asset Management Americas Inc. increased its stake in shares of Cardiovascular Systems by 809.3% in the first quarter. UBS Asset Management Americas Inc. now owns 8,393 shares of the medical device company’s stock valued at $237,000 after buying an additional 7,470 shares during the last quarter. Finally, US Bancorp DE increased its stake in shares of Cardiovascular Systems by 14.3% in the first quarter. US Bancorp DE now owns 8,708 shares of the medical device company’s stock valued at $246,000 after buying an additional 1,091 shares during the last quarter. Hedge funds and other institutional investors own 75.85% of the company’s stock.

Institutional Ownership by Quarter for Cardiovascular Systems (NASDAQ:CSII)

Shares of Cardiovascular Systems, Inc. (NASDAQ CSII) opened at 31.09 on Friday. The stock’s market capitalization is $1.02 billion. The stock has a 50 day moving average price of $30.95 and a 200 day moving average price of $27.71. Cardiovascular Systems, Inc. has a one year low of $16.57 and a one year high of $32.68.

Cardiovascular Systems (NASDAQ:CSII) last announced its earnings results on Wednesday, May 3rd. The medical device company reported ($0.05) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.05). The company had revenue of $52.10 million for the quarter, compared to analyst estimates of $51.13 million. Cardiovascular Systems had a negative return on equity of 4.36% and a negative net margin of 3.72%. The firm’s quarterly revenue was up 17.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.31) earnings per share. Equities analysts forecast that Cardiovascular Systems, Inc. will post ($0.13) earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Clinton Group Inc. Purchases New Position in Cardiovascular Systems, Inc. (CSII)” was posted by Financial Market News and is the sole property of of Financial Market News. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this piece of content can be read at https://www.financial-market-news.com/2017/06/17/clinton-group-inc-purchases-new-position-in-cardiovascular-systems-inc-csii.html.

Several equities research analysts have recently weighed in on the company. TheStreet upgraded Cardiovascular Systems from a “d” rating to a “c-” rating in a report on Thursday, May 4th. Zacks Investment Research upgraded Cardiovascular Systems from a “hold” rating to a “buy” rating and set a $31.00 price target on the stock in a report on Tuesday, March 7th. BidaskClub upgraded Cardiovascular Systems from a “hold” rating to a “buy” rating in a report on Friday, June 9th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $32.00 price target on shares of Cardiovascular Systems in a report on Tuesday, April 18th. Two analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $33.00.

Cardiovascular Systems Company Profile

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems, Inc. (NASDAQ:CSII).

Receive News & Ratings for Cardiovascular Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.